Aquestive Therapeutics (AQST) Tax Rate (2023 - 2024)

Aquestive Therapeutics (AQST) recorded quarterly Tax Rate of 0.08% in Q4 2024, up 106.5% quarter-over-quarter from 1.26% in Q4 2023, and up 134.0% on a YoY basis from 0.04% in Q1 2024.

Aquestive Therapeutics (AQST) Tax Rate (2023 - 2024) Analysis & Trends

Aquestive Therapeutics' Tax Rate history runs 2 years deep, the most recent figure standing at 0.08% for Q4 2024.

  • In Q4 2024, Tax Rate rose 134.0% year-over-year to 0.08%; the TTM figure through Mar 2025 stood at 0.03% (up 88.0% YoY), while the FY2024 annual figure was 0.03%, up 324.0% from the prior year.
  • Tax Rate was 0.08% for Q4 2024 at Aquestive Therapeutics, up from 1.26% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 6.44% in Q3 2023 to a low of 5.16% in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 15.33%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 20.71%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 13.63%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -20.44%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 19.81%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 34.48%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -7.43%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 9.29%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 24.29%
10 Aquestive Therapeutics 488.60 Mn 377.87 Mn 10.98 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 0.08%
Dec 31, 2024 0.08%
Dec 31, 2023 -1.26%
Dec 31, 2023 -1.26%
Sep 30, 2023 6.44%
Sep 30, 2023 6.44%
Jun 30, 2023 -5.16%
Jun 30, 2023 -5.16%